• A Lithuanian Case of Tyrosinemia Type 1 with a Literature Review: A Rare Cause of Acute Liver Failure in Childhood
• A patient with urinary succinylacetone-negative hereditary tyrosinemia type 1
• Adult female with severe decompensation of tyrosinaemia type 1 that responds to heme treatment
• Alkaptonuria - Past, present and future
• An engineered Escherichia coli Nissle strain prevents lethal liver injury in a mouse model of tyrosinemia type 1
• An Infant with Bilateral Keratitis: From Infectious to Genetic Diagnosis
• Application of machine learning tools and integrated OMICS for screening and diagnosis of inborn errors of metabolism
• Clinical features and genetic analysis of a child with acute form of Tyrosinemia type I due to a novel variant of FAH gene
• Comprehensive Evaluation of the NeoBase 2 Non-derivatized MSMS Assay and Exploration of Analytes With Significantly Different Concentrations Between Term and Preterm Neonates
• Consenso mexicano de tirosinemia tipo 1
• Corneal Crystals in Patients With Tyrosinemia Types I and II
• Current Landscape on Development of Phenylalanine and Toxicity of its Metabolites - A Review
• Current Landscape on Development of Phenylalanine and Toxicity of its Metabolites- A Review
• Determinants of tyrosinaemia during nitisinone therapy in alkaptonuria
• E. coli´s fight against TYROnny: Designing a bacterial strain to tackle tyrosinemia type 1
• E. colis fight against TYROnny: Designing a bacterial strain to tackle tyrosinemia type 1
• Efficient expansion and CRISPR-Cas9-mediated gene correction of patient-derived hepatocytes for treatment of inherited liver diseases
• Emotional and behavioural functioning in children with tyrosinaemia type 1
• Engineering a transposon-associated TnpB-ωRNA system for efficient gene editing and phenotypic correction of a tyrosinaemia mouse model
• Evaluation of a New 'Mix-In' Style Glycomacropeptide-Based Protein Substitute for Food and Drinks in Patients with Phenylketonuria and Tyrosinemia
• Ex vivo gene editing and cell therapy for hereditary tyrosinemia type 1
• From skin lesions to tyrosinemia type II diagnosis
• Hereditary Tyrosinemia Type 1 Mice under Continuous Nitisinone Treatment Display Remnants of an Uncorrected Liver Disease Phenotype
• Hypertyrosinemia
• Identification and functional characterization of a novel homozygous intronic variant in the fumarylacetoacetate hydrolase gene in a Chinese patient with tyrosinemia type 1
• Maleic acid is a biomarker for maleylacetoacetate isomerase deficiency; implications for newborn screening of tyrosinemia type 1
• Modified by the Innovative Drugs and Strategies-Pattern of Selected Indications for Pediatric Liver Transplantation
• Novel HPD mutation p.A244V compound with p.T219M causing tyrosinemia type III in a Chinese girl and review of the genotype-phenotype spectrum
• Nutritional interventions for patients with alkaptonuria: A minireview
• Revitalizing liver function in mice with liver failure through transplantation of 3D-bioprinted liver with expanded primary hepatocytes
• Structure-based discovery of pyrazole-benzothiadiazole hybrid as human HPPD inhibitors
• The compound heterozygous mutations of c.607G>a and c.657delC in the FAH gene are associated with renal damage with hereditary tyrosinemia type 1 (HT1)
• The effects of phenylalanine and tyrosine levels on dopamine production in rat PC12 cells. Implications for treatment of phenylketonuria, tyrosinemia type 1 and comorbid neurodevelopmental disorders
• The mutation spectrum and ethnic distribution of non-hepatorenal tyrosinemia (types II, III)
• UK Dietary Practices for Tyrosinaemias: Time for Change
• UK should screen for tyrosinaemia in newborn babies, committee recommends